Cardiovascular Diseases Research in Wisconsin
Cardiovascular Diseases Research (93.837) awarded $335 million to recipients in Wisconsin in 251 grants from fiscal 2021 to 2025, 2.3% of the program's national total. The Medical College of Wisconsin, Inc. received the most, $154 million.
- Awarded in Wisconsin$335 million
- Awards251
- Share of the program2.3%
- Rank among states15th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 129 | $70.8 million |
| FY 2022 | 129 | $67.4 million |
| FY 2023 | 125 | $68.7 million |
| FY 2024 | 120 | $63.0 million |
| FY 2025 | 115 | $64.7 million |
Recipients in Wisconsin
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical College of Wisconsin, Inc. | Colleges and universities | 121 | $154 million |
| University of Wisconsin System | Colleges and universities | 79 | $91.3 million |
| Versiti Blood Health, Inc. | Nonprofits | 27 | $67.8 million |
| The Morgridge Institute for Research, Inc. | Nonprofits | 3 | $8.9 million |
| Reneurogen LLC | Small businesses | 2 | $4.0 million |
| Retham Technologies, Inc. | Small businesses | 1 | $2.9 million |
| Marquette University | Colleges and universities | 4 | $1.8 million |
| Madeleine Pharmaceuticals Inc | Small businesses | 1 | $1.0 million |
| Cellular Logistics, Inc. | Small businesses | 2 | $657,772 |
| Invivosciences, Inc. | Small businesses | 1 | $493,728 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Wisconsin?
$335 million from fiscal 2021 to 2025, across 251 awards. Wisconsin ranks 15th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Wisconsin?
The largest recipient is The Medical College of Wisconsin, Inc., with $154 million in 121 awards. Next are University of Wisconsin System and Versiti Blood Health, Inc..
Can organizations in Wisconsin apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Wisconsin
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program